MedPath

Clinical Study on Collagen Peptide of Titan Biotech Limited for Skin, Nail and Hair Health in Adults.

Not Applicable
Completed
Registration Number
CTRI/2019/06/019857
Lead Sponsor
Titan Biotech Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
72
Inclusion Criteria

1.Adults between 18 and 45 years of age (both ages and all sexes inclusive)

2.Subjects with any skin type with a minimum of one concern

i.Wrinkles

ii.Dry, Dull Skin

iii.Brittle Nails

iv.Dry, Dull Hair

v.Hair Fall, Breakage

vi.Split Ends of the hair

3.Subject/LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period and follow up period.

4.Subjects who are willing not to participate in any other clinical trial during participation in the current trial.

Exclusion Criteria

1.Subjects with known hypersensitivity to investigational product or its constituents.

2.Subjects who have skin condition that prevent proper examination or evaluation of study criteria.

3.Subjects who are on active treatments for skin and/or hair conditions.

4.Subjects who have dyed their hair in the last 60 days.

5.Subjects with immunucompromised state complications.

6.Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.), any medical condition that is unstable/poorly controlled or other factor (e.g., planned relocation) that the Investigator felt would interfere with study evaluations and study participation.

7.Females who are pregnant or lactating or planning to become pregnant during the study period.

8.Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol.

9.Subjects, who in the opinion of the Investigator or the Medical Experts are not eligible for enrolment in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Skin Improvement Questionnaire : Total Score of â?¥20 by end of study <br/ ><br>2.60 Second Hair Count Test: Reduction of â?¥20% by end of study <br/ ><br>3.Hair Growth Questionnaire : Total Score of â?¥20 by end of study <br/ ><br>4.Nail Health Questionnaire: Total Score of â?¥20 by end of study <br/ ><br>Timepoint: 1.Skin Improvement Questionnaire : Day1,Day 45, Day 90 <br/ ><br>2.60 Second Hair Count Test: Day1,Day 45, Day 90 <br/ ><br>3.Hair Growth Questionnaire : Day1,Day 45, Day 90 <br/ ><br>4.Nail Health Questionnaire:Day1,Day 45, Day 90 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath